insights_auto
Why is BOT up 22.22%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.011
arrow_upward
+22.22%(+0.0020) 1D
Nov 5, 4:10:30 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
30.39M
Avg. vol.
9.08M
Volume
7.72M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
30.39M
Avg. vol.
9.08M
Volume
7.72M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
FXStreet
·
17 minutes ago
Dow has best day since April 2025 as Brent drops 8.7% after Vance blames the Iran war
Business Insider
·
25 minutes ago
The S&P 500 is flashing a rare signal that hints a recession and a sharp stock drop are looming
Yahoo Finance UK
·
1 hour ago
Why Tesla stock fell as the S&P 500 climbed after the US midterms
Investing.com
·
4 hours ago
S&P 500 Faces a Fresh Test as Friday’s Jobs Report Approaches
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorPharmaceutical industry
Industry-
Websitebotanixpharma.com